Kun Yu Selected Research

Thyroidectomy

10/2020	Multimodal treatment based on thyroidectomy improves survival in patients with metastatic anaplastic thyroid carcinoma: a SEER analysis from 1998 to 2015.
1/2019	Effect of adjuvant radioactive iodine therapy on survival in rare oxyphilic subtype of thyroid cancer (Hürthle cell carcinoma).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kun Yu Research Topics

Disease

45	Neoplasms (Cancer) 01/2024 - 05/2004
16	Wounds and Injuries (Trauma) 12/2023 - 01/2016
13	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2004
12	Inflammation (Inflammations) 12/2023 - 01/2012
9	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2008
7	Hemorrhage 09/2023 - 12/2015
6	Myocardial Infarction 11/2023 - 01/2019
5	Colitis 02/2024 - 01/2018
5	Reperfusion Injury 11/2023 - 02/2011
5	Hypoxia (Hypoxemia) 06/2022 - 12/2017
5	Carcinoma (Carcinomatosis) 01/2020 - 08/2004
4	Bacterial Infections (Bacterial Infection) 12/2023 - 10/2018
4	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 07/2008
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2014
4	Thyroid Neoplasms (Thyroid Cancer) 04/2022 - 08/2017
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022 - 01/2019
4	Infections 05/2021 - 12/2006
4	Stomach Neoplasms (Stomach Cancer) 12/2020 - 06/2008
4	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 06/2011
3	Thrombosis (Thrombus) 06/2024 - 07/2011
3	Colonic Neoplasms (Colon Cancer) 01/2024 - 01/2015
3	Hyperglycemia 12/2023 - 12/2010
3	Ischemia 01/2023 - 06/2011
3	Myocarditis (Carditis) 01/2022 - 08/2017
3	Necrosis 01/2019 - 01/2018
3	Hemolysis 02/2018 - 06/2011
2	Body Weight (Weight, Body) 02/2024 - 10/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2024 - 05/2018
2	Melanoma (Melanoma, Malignant) 01/2024 - 01/2014
2	Hyperoxia 11/2023 - 02/2023
2	Lung Injury 11/2023 - 02/2023
2	Neuroinflammatory Diseases 11/2023 - 01/2018
2	Cardiomegaly (Heart Hypertrophy) 10/2023 - 01/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2022 - 01/2022
2	Atherosclerosis 02/2022 - 01/2022
2	Septic Shock (Toxic Shock Syndrome) 01/2022 - 02/2019
2	Papillary Thyroid Cancer 01/2022 - 01/2016
2	Constipation 01/2022 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2021
2	Infarction (Infarctions) 08/2021 - 01/2019
2	Infertility (Sterility) 01/2021 - 12/2020
2	Endocrine System Diseases (Endocrine Diseases) 01/2021 - 01/2019
2	Rheumatoid Arthritis 01/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 08/2023 - 04/2008
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2008
7	Estrogen ReceptorsIBA 01/2021 - 05/2004
6	CytokinesIBA 02/2024 - 01/2012
6	ChitosanIBA 12/2023 - 01/2016
6	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2021
6	Messenger RNA (mRNA)IBA 01/2022 - 04/2008
5	Hemostatics (Antihemorrhagics)IBA 01/2023 - 12/2015
5	Therapeutic UsesIBA 11/2022 - 12/2017
4	Interleukin-6 (Interleukin 6)IBA 02/2023 - 05/2018
4	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2014
4	Caspase 3 (Caspase-3)IBA 08/2021 - 01/2014
4	Small Interfering RNA (siRNA)IBA 08/2017 - 07/2008
3	Fibroins (Fibroin)IBA 12/2023 - 09/2017
3	Sirolimus (Rapamycin)FDA Link 11/2023 - 07/2008
3	GelatinIBA 09/2023 - 01/2016
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2023 - 01/2017
3	LipidsIBA 12/2022 - 10/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 07/2008
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2012
3	Estrogens (Estrogen)FDA Link 01/2022 - 01/2019
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2021 - 01/2012
3	Long Noncoding RNAIBA 01/2021 - 01/2019
3	Phenobarbital (Luminal)FDA Link 12/2019 - 08/2004
3	GoldIBA 12/2018 - 11/2017
3	6-formylindolo(3,2-b)carbazoleIBA 10/2018 - 01/2018
2	Blood Coagulation Factors (Coagulation Factor)IBA 03/2024 - 09/2023
2	Glycoproteins (Glycoprotein)IBA 02/2024 - 01/2024
2	Dextran SulfateIBA 02/2024 - 01/2019
2	SwainsonineIBA 01/2024 - 08/2023
2	Polysaccharides (Glycans)IBA 12/2023 - 04/2022
2	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 10/2016
2	Toll-Like Receptor 4IBA 11/2023 - 01/2023
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2023 - 05/2018
2	Amino Acids FDA Link 10/2023 - 06/2015
2	Silk FDA Link 07/2023 - 01/2017
2	CalciumIBA 03/2023 - 05/2022
2	Thrombin FDA Link 01/2023 - 10/2022
2	Imatinib Mesylate (Gleevec)FDA Link 10/2022 - 01/2022
2	Mitochondrial Permeability Transition PoreIBA 05/2022 - 05/2011
2	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 05/2022 - 08/2017
2	Superoxide DismutaseIBA 05/2022 - 01/2019
2	Malondialdehyde (Propanedial)IBA 05/2022 - 01/2019
2	oxidized low density lipoproteinIBA 02/2022 - 01/2022
2	ResveratrolIBA 01/2022 - 10/2021
2	HydrogelsIBA 11/2021 - 12/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 10/2018
2	Tamoxifen FDA LinkGeneric 01/2021 - 09/2006
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2021 - 09/2006

Therapy/Procedure

19	Therapeutics 06/2024 - 07/2008
5	Drug Therapy (Chemotherapy) 10/2021 - 07/2008
5	Extracorporeal Membrane Oxygenation 08/2016 - 12/2009
2	Neoadjuvant Therapy 01/2022 - 12/2019
2	Critical Care (Surgical Intensive Care) 01/2022 - 02/2019
2	Operative Surgical Procedures 01/2022 - 12/2021
2	Ligation 01/2022 - 08/2021
2	Aftercare (After-Treatment) 01/2022 - 01/2014